ATARA BIOTHERAPEUTICS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2016 | $9.1M | $313.0M | $22.1M |
| Jun 2016 | $10.6M | $300.8M | $26.4M |
| Sep 2016 | $14.2M | $284.4M | $46.0M |
| Dec 2016 | $10.2M | $263.9M | $48.0M |
| Mar 2017 | $8.6M | $241.7M | $62.4M |
| Jun 2017 | $23.0M | $244.2M | $64.2M |
| Sep 2017 | $23.7M | $229.7M | $60.5M |
| Dec 2017 | $39.9M | $217.8M | $79.2M |
| Mar 2018 | $33.9M | $473.1M | $90.5M |
| Jun 2018 | $40.2M | $492.7M | $103.2M |
| Sep 2018 | $39.9M | $442.9M | $66.0M |
| Dec 2018 | $53.0M | $391.8M | $60.7M |
| Mar 2019 | $40.8M | $324.7M | $56.2M |
| Jun 2019 | $41.9M | $274.1M | $59.2M |
| Sep 2019 | $46.3M | $364.8M | $94.4M |
| Dec 2019 | $52.2M | $342.9M | $74.3M |
| Mar 2020 | $46.7M | $299.5M | $70.2M |
| Jun 2020 | $47.0M | $428.1M | $74.5M |
| Sep 2020 | $51.6M | $405.5M | $62.6M |
| Dec 2020 | $125.8M | $588.1M | $200.4M |
| Mar 2021 | $130.6M | $529.6M | $151.1M |
| Jun 2021 | $125.3M | $456.8M | $123.9M |
| Sep 2021 | $139.8M | $449.9M | $113.2M |
| Dec 2021 | $188.5M | $468.1M | $106.1M |
| Mar 2022 | $173.0M | $397.3M | $101.7M |
| Jun 2022 | $178.6M | $436.1M | $70.7M |
| Sep 2022 | $181.2M | $368.3M | $65.1M |
| Dec 2022 | $249.8M | $376.4M | $92.9M |
| Mar 2023 | $237.1M | $302.1M | $48.7M |
| Jun 2023 | $239.0M | $246.4M | $45.9M |
| Sep 2023 | $239.6M | $188.8M | $64.8M |
| Dec 2023 | $264.7M | $165.5M | $25.8M |
| Mar 2024 | $263.6M | $165.3M | $35.1M |
| Jun 2024 | $228.2M | $117.3M | $31.3M |
| Sep 2024 | $233.2M | $142.7M | $46.5M |
| Dec 2024 | $206.4M | $109.1M | $25.0M |
| Mar 2025 | $117.1M | $62.0M | $13.8M |
| Jun 2025 | $71.9M | $36.9M | $16.9M |
| Sep 2025 | $66.8M | $30.2M | $5.7M |
| Dec 2025 | $58.7M | $20.2M | $8.5M |